Mesalazine (Octasa)

Indications

Mild-to-moderately active UC, acute attacks and remission maintenance in adults and children. Some preparations are not licensed for use in children.

Contraindications

Blood clotting abormalities; pulmonary disease; salicylate hypersensitivity; pregnancy; hepatic impairment. Use with caution in elderly patients. Monitor breast-fed infants for diarrhoea. | Potential side effects: Joint pain; cough; diarrhoea; dizziness; fever; gastrointestinal discomfort; headache; low white blood cell count; nausea; skin reactions; vomiting

Preparations Available

Oral tablet/granules, rectal foam, enema, suppository

Quantity

Dose: Octasa: Induction (UC), 2.4 g ×1 or 2.4–4.8 g DD; Maintenance (UC and Crohn’s ileo-colitis), 1.2–2.4 g ×1 or DD

Sizes Available

400mg (90), £19.50; 800mg (180), £80.75

Price

400mg (90), £19.50; 800mg (180), £80.75

More on: Aminosalicylates